Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic and the duration of protective immunity to the virus is unknown. Cases of persons …
JY Ahn, Y Sohn, SH Lee, Y Cho, JH Hyun… - Journal of Korean …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has …
LLM Poon, M Peiris - Nature medicine, 2020 - nature.com
Emergence of a novel human coronavirus threatening human health | Nature Medicine Skip to main content Thank you for visiting nature.com. You are using a browser version with limited …
JK Files, S Boppana, MD Perez… - The Journal of …, 2021 - Am Soc Clin Investig
Ongoing observational clinical research has prioritized understanding the human immune response to SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic …
It is now 6 weeks since Chinese health authorities announced the discovery of a novel coronavirus (2019-nCoV)[1] causing a cluster of pneumonia cases in Wuhan, the major …
The first edition of this document was published in 2013 and was revised in 2015. The current version is aligned with other WHO documents on case definitions and laboratory …
The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one …
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate …
S Batawi, N Tarazan, R Al-Raddadi, E Al Qasim… - Health and quality of life …, 2019 - Springer
Introduction Data are lacking on impact of Middle East Respiratory Syndrome (MERS) on health-related quality of life (HRQoL) among survivors. Methods We conducted a cross …